APUS · Apimeds Pharmaceuticals US, Inc.
$5.65
+5.00 (+764.84%)
At close · Jul 24
Going-concern doubt
— flagged May 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not contain any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed May 26, 2026
Market Cap
$85.27M
Shares
15.09M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.